COVID-19

All our coronavirus coverage for the globaldev community in one place: news, jobs, funding

The latest on how the coronavirus is affecting global development. Visit the COVID-19 timeline and read who's funding the COVID-19 response for more details. Check this page regularly for news in addition to career and funding opportunities. We’ve lifted our paywall on all COVID-19 coverage to provide access to accurate information and resources during the pandemic. Please consider a Devex Pro subscription to support our journalism.

A timeline of the coronavirus outbreak

Latest news

Inclusive development

Humanitarian sector failing older people in emergencies, report finds

By Rumbi Chakamba

Advocates say the needs of older people in humanitarian situations are often forgotten, and that the situation has "gone on for far too long."

Widespread COVID-19 vaccination in Africa will likely start mid-2021

Unique challenges mean widespread campaigns to distribute COVID-19 vaccines in Africa will likely start in the second quarter of 2021, says John Nkengasong, Africa CDC director.

COVID-19 vaccine work for UNICEF is about to become more intense. Here's why.

UNICEF's vaccine deputy explains what logistical hurdles need to be overcome — and what opportunities exist — as the agency prepares to help roll out vaccines, as early as the next few months.

Opinion: The parallel pandemic — sexual violence

COVID-19 has exacerbated the parallel pandemic of violence against women and children. Two human rights leaders discuss why "building back safer" — protecting women and children from violence — must be an essential component of the public health response.

Few results from G-20 meeting as decisions await new US administration

The G-20 affirmed some decisions on debt and included typically vague language on issues from COVID-19 response to climate, but the lack of action has left the door open for the next U.S. presidential administration.

The Oxford-AstraZeneca COVID-19 vaccine shows 62% to 90% efficacy

Interim analysis of the University of Oxford and AstraZeneca vaccine candidate shows high efficacy rates — but questions on the data remain, meaning a full review is required.

Where the US stands on G-20 debt deals, SDRs, and global COVID-19 response

Brent McIntosh, under secretary for international affairs at the U.S. Treasury Department, laid out the U.S. position on G-20 debt discussions and global COVID-19 funding through IMF last week.

Will these 3 gender data trends outlast the pandemic?

As some in-person data collection resumes — with masked researchers at a safe distance — organizations are beginning to evaluate which of the gender data collection methods adopted in crisis should remain.

Opinion: Why exciting results from vaccine research are just the beginning of efforts to end COVID-19

Decades of research and advocacy that led to achievements in HIV provide important lessons for the global responses to COVID-19.

Opinion: How AI can push for equitable access to COVID-19 vaccines

This op-ed explores three ways pharmaceutical companies’ adoption of artificial intelligence technologies in supply chain activities can benefit the access-to-medicine issue.

Opinion: How can DFIs do more to help MSMEs survive COVID-19?

Following the Finance in Common Summit last week, this op-ed outlines how DFIs can better support micro-, small-, and medium-sized enterprises with a greater focus on social, environmental, gender, and poverty dimensions.

See more coverage

Sponsored Content

Opinion: The COVID-19 gender mortality gap — is civil registration the answer?

Harnessing the power of data and digital technology for health transformation in the COVID-19 recovery

Funding news

The World Bank approves $12B for vaccine finance. Will other financial institutions follow?

IDB's Claver-Carone outlines plans for COVID-19 recovery, capital increase

Is World Bank fast-track COVID-19 funding reaching the most vulnerable?

Proposals and pressure mount for more action on COVID-19 financing

Jobs

See more jobs

Funding update

See all COVID-related funding

Candidates

See all COVID-19 relevant candidates

COVID-19 Trends Tracker

Top Read